A detailed history of Zullo Investment Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Zullo Investment Group, Inc. holds 11,274 shares of MRK stock, worth $1.12 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
11,274
Previous 11,409 1.18%
Holding current value
$1.12 Million
Previous $1.41 Million 9.35%
% of portfolio
0.53%
Previous 0.62%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$111.15 - $128.97 $15,005 - $17,410
-135 Reduced 1.18%
11,274 $1.28 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $7,428 - $7,977
-60 Reduced 0.52%
11,409 $1.41 Million
Q1 2024

Apr 24, 2024

BUY
$113.24 - $131.95 $5,435 - $6,333
48 Added 0.42%
11,469 $1.51 Million
Q4 2023

Jan 19, 2024

BUY
$100.18 - $109.02 $15,327 - $16,680
153 Added 1.36%
11,421 $1.25 Million
Q3 2023

Oct 19, 2023

BUY
$102.95 - $114.33 $43,547 - $48,361
423 Added 3.9%
11,268 $1.16 Million
Q2 2023

Jul 19, 2023

BUY
$108.61 - $118.38 $6,299 - $6,866
58 Added 0.54%
10,845 $1.25 Million
Q1 2023

Apr 25, 2023

BUY
$102.94 - $114.86 $12,970 - $14,472
126 Added 1.18%
10,787 $1.15 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $7,432 - $9,529
85 Added 0.8%
10,661 $1.18 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $15,384 - $17,282
182 Added 1.75%
10,576 $911,000
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $5,009 - $5,678
-60 Reduced 0.57%
10,394 $948,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $22,567 - $25,296
307 Added 3.03%
10,454 $858,000
Q4 2021

Feb 16, 2022

BUY
$72.28 - $90.54 $733,425 - $918,709
10,147 New
10,147 $778,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Zullo Investment Group, Inc. Portfolio

Follow Zullo Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Zullo Investment Group, Inc. with notifications on news.